Medicare Enrolled
Dr. Maria Valente, M.D.
Hematology & Oncology · Jacksonville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Valente from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Valente?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Valente
Dr. Maria Valente is a hematology & oncology specialist in Jacksonville, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Valente performed 15,010 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Valente received a total of $1,416 from 48 pharmaceutical and/or device companies across 87 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Valente is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 24% volume in FL
$1,416 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 79666 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗15,010
Medicare services
Top 24% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,260 | $18 | $39 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,800 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,540 | $6 | $27 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
956 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
810 | $8 | $41 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
807 | $8 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
494 | $93 | $162 |
| Anti-nausea injection (Aloxi/palonosetron) | 380 | $1 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
276 | $64 | $104 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
267 | $10 | $42 |
| Injection, granisetron hydrochloride, 100 mcg | 260 | $0 | $41 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
157 | $97 | $355 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
118 | $22 | $90 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
104 | $7 | $282 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
101 | $1 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
98 | $48 | $160 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
96 | $12 | $55 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
68 | $70 | $70 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
56 | $63 | $115 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
48 | $2 | $97 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
47 | $9 | $40 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
43 | $1 | $4 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $120 | $265 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
24 | $55 | $500 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $103 | $225 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
21 | $21 | $130 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
21 | $55 | $104 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 21 | $401 | $1,000 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
20 | $1,098 | $2,400 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $37 | $74 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
19 | $172 | $535 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
17 | $5 | $29 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $137 | $330 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.9% high complexity
79.1% medium
18.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,416
Total received (2018-2024)
Avg $202/year across 7 years
Bottom 33% in FL for hematology & oncology
48
Companies
87
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$386
2023
$147
2022
$287
2021
$204
2020
$162
2019
$122
2018
$108
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$66
Menarini Silicon Biosystems, Inc.
$51
Janssen Biotech, Inc.
$46
Alexion Pharmaceuticals, Inc.
$41
Celgene Corporation
$37
Daiichi Sankyo Inc.
$35
PFIZER INC.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
GENZYME CORPORATION
$15
Merck Sharp & Dohme LLC
$15
Agios Pharmaceuticals, Inc.
$14
ABBVIE INC.
$13
ARRAY BIOPHARMA INC
$13
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$162
MACROGENICS, INC.
$93
Alexion Pharmaceuticals, Inc.
$91
Daiichi Sankyo Inc.
$62
Menarini Silicon Biosystems, Inc.
$51
Astellas Pharma US Inc
$51
Foundation Medicine, Inc.
$49
Janssen Biotech, Inc.
$46
PFIZER INC.
$46
GENZYME CORPORATION
$38
Gilead Sciences, Inc.
$37
Celgene Corporation
$37
Genentech USA, Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$34
TG THERAPEUTICS, INC.
$31
Merck Sharp & Dohme LLC
$30
BeiGene USA, Inc.
$29
MorphoSys, US Inc.
$29
Taiho Oncology, Inc.
$29
ABBVIE INC.
$28
Acceleron Pharma, Inc.
$27
Octapharma USA, Inc.
$25
Exelixis Inc.
$25
Mirati Therapeutics, Inc.
$21
Blue Earth Diagnostics Limited
$17
CTI BioPharma Corp.
$15
Dova Pharmaceuticals
$15
Janssen Pharmaceuticals, Inc
$15
TESARO, Inc.
$15
AVEO Pharmaceuticals, Inc.
$15
Agios Pharmaceuticals, Inc.
$14
CSL Behring
$13
ARRAY BIOPHARMA INC
$13
R-Pharm US LLC
$13
MEDIVATION FIELD SOLUTIONS LLC
$13
Aurobindo Pharma USA, Inc.
$13
SERVIER PHARMACEUTICALS LLC
$13
Global Blood Therapeutics, Inc.
$12
Ipsen Biopharmaceuticals, Inc
$12
Incyte Corporation
$12
Rigel Pharmaceuticals, Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$12
PUMA BIOTECHNOLOGY, INC.
$11
Emmaus Medical, Inc.
$11
Bayer HealthCare Pharmaceuticals Inc.
$11
Eisai Inc.
$11
Merck Sharp & Dohme Corporation
$11
Sunovion Pharmaceuticals Inc.
$11
Top 3 companies account for 24.4% of all-time payments
Associated products mentioned in payments ›
AKYNZEO · ALUNBRIG · Axumin · BOSULIF · BRUKINSA · CABLIVI · Cellsearch · Doptelet · EPKINLY · Endari · Enhertu · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · INJECTAFER · INQOVI · Idelvion · Ixempra · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LUTATHERA · Lenvima · MARGENZA · MEKINIST · MONJUVI · NERLYNX · OXBRYTA · PADCEV · PANZYGA · PROMACTA · Pomalyst · RYBREVANT · Reblozyl · Rezlidhia · SOMATULINE DEPOT · TECENTRIQ · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · Utibron · VENCLEXTA · VOTRIENT · Vanflyta · Vonjo · XALKORI · XARELTO · XOSPATA · XTANDI · Xofigo · ZEJULA · Zevalin
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
103
County median income
$68,447
Nearest hospital to ZIP centroid (approximate)
MAYO CLINIC
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Valente is a mixed practice specialist, with above-average Medicare volume (top 24% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Valente experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Valente performed 4,260 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Valente receive payments from pharmaceutical companies?
Yes. Dr. Valente received a total of $1,416 from 48 companies across 87 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Valente's costs compare to other hematology & oncology specialists in Jacksonville?
Dr. Valente's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Valente) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Jacksonville
Browse hematology & oncology specialists in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
MACROGENICS, INC. Payments to Doctors
See all physicians who received payments from MACROGENICS, INC.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology